PIR and cancer: Following above clues, we investigated in depth the molecular mechanism underlying PIR inhibition of cancer cell apoptosis and found that NFκB2 rather than NFκB1 is involved in PIR regulation of apoptosis by establishing the PIR‐NIK‐NFκB2‐FAS regulatory axis.